24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
TASE
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
16:24
Full list of Israeli high-tech funding rounds in 2025
16:00
Ex-Cognigo founders raise $20M Series A to bring AI automation to CFOs
15:08
How Google’s Veo 3 became a weapon for racist propaganda on TikTok
11:46
Elon Musk’s Grok sparks outrage with pro-Hitler rants
More stories
Buzz
Most popular
Daily
Weekly
1
Intel offers up to 19 salaries to laid-off employees if they don’t fight firings
2
Israel’s Weizmann Institute reels from Iranian attack, faces $300 million hole
3
Inside Intel's painful cuts: Who's being let go and why
4
Intel CEO: "The strength, resilience and resolve of Intel Israel's team has no bounds"
5
Remote work’s dark side: The Soham Parekh story
More news
TASE
20 stories about TASE
Spacecom's Controlling Stake Headed to TASE
12.08.19
|
Golan Hazani
The 54% stake is held by five Israeli institutional investors since controlling shareholder Eurocom went into receivership in 2018
Cannabis Pharmaceutical Outfit Nextage Wants to Raise $15 Million in Canada
04.08.19
|
Tzally Greenberg
The company, which is currently in the process of merging with Tel Aviv-listed Micromedic Technologies, intends to use the funding to build a manufacturing facility for its products in Israel and to continue developing its pipeline
Tel Aviv Stock Exchange Completes Public Stage of Offering
30.07.19
|
Raheli Bindman
The general public was offered stock worth $6.5 million with a cap of $8,500 per investor. Over 1,000 private investors participated in the public stage, through brokers and bank consultants
TASE Stock IPO Oversubscribed
29.07.19
|
Raheli Bindman
The Tel Aviv Stock Exchange will be closing the pricing stage of its stock offering Monday
Upcoming TASE IPO Could Net its International Shareholders a 40% Premium
15.07.19
|
Raheli Bindman
In 2018, TASE sold most of its securities to five international funds. Now 31.7% is being offered to institutional investors and the public
TASE IPO Vision Leads CEO to Clash With Regulator
10.06.19
|
Raheli Bindman
TASE CEO Ittai Ben-Zeev wants to offer shares in the exchange exclusively to the general public, but the Israel Securities Authority has not approved the model
The Tel Aviv Stock Exchange Sets Public Offering Date for July
21.05.19
|
Golan Hazani
In 2018, TASE CEO Ittai Ben-Zeev led the sale of most the exchange to five international investors, in an attempt to make it more global. A 33% stake has been held in trust since, to be offered to the public
Israel's Top Cannabis Companies Lost a Combined $307 Million on TASE
20.05.19
|
Tzally Greenberg
Over the last three months, the combined market capitalization of Israel's eight leading medical cannabis companies dropped to $475 million
Teva no Longer Largest Company on TASE After U.S. Legal Troubles Sink Stock
13.05.19
|
Lilach Baumer
International Flavors & Fragrances (IFF), which listed on the Tel Aviv exchange in October following its acquisition of Israel-based Frutarom, has now surpassed the Israeli drugmaker
Enlight Renewable Energy Closes Stock Offering with $62 Million Committed
21.04.19
|
CTech
On Tuesday, Enlight announced it is in talks to acquire a 100% stake in a wind energy venture in northwest Europe
Cannabis Producer Cannbit Raises Almost $9 Million in Public Offering
21.04.19
|
Tzally Greenberg
The Israeli company will now petition the Tel Aviv Stock Exchange to move from the maintenance list to the primary list
Teva Execs Topped TASE's High Earners List for 2018
18.04.19
|
Gil Kalian
With nearly $34 million added to the bank, Teva’s CEO Kåre Schultz was the highest earning executive on the Tel Aviv Stock Exchange last year
Cannabis Producer Cannbit Wants to Raise up to $9 Million on the Tel Aviv Exchange
18.04.19
|
Tzally Greenberg
The Israel-based company is considering offering up to 20% of its registered capital at NIS 18 ($5) per share
Elbit Intends to Raise $186 in Private Offering
09.04.19
|
Golan Hazani
The defense contractor announced it has obtained the commitment of several Israeli institutional investors to acquire 1.4 million shares at a price of $132 per share
Email Protection Company Cyren to Delist from Tel Aviv Exchange on Wednesday
04.04.19
|
Lilach Baumer
Cyren was founded in Israel in 1991 as an email services provider and changed direction after its 1999 Nasdaq IPO
Anchiano Therapeutics Schedules TASE Delisting
14.03.19
|
Lilach Baumer
Based in Jerusalem and Cambridge, Massachusetts, clinical-stage Anchiano develops gene therapies for cancer, with a special focus on bladder cancer
The Tel Aviv Stock Exchange Wants to Hitch a Ride With Gett
14.03.19
|
Meir Orbach and Raheli Bindman
The exchange has approached Gett in recent weeks to explore a plan to float the ride-hailing company locally
Itamar Medical Starts Trading ADS on Nasdaq
27.02.19
|
Lilach Baumer
The Tel Aviv-listed medical diagnosis company received SEC approval for listing its ADS on the American exchange
Cancer Freezing Company IceCure Raises Just Third of Planned Offering
21.02.19
|
Tzally Greenberg
IceCure develops an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor, freezing its tissue
In Tel Aviv, Reform Sends Cannabis Stocks Down as Shareholders Sell High
28.01.19
|
Lilach Baumer
On Sunday, the Israeli government gave the final stamp of approval to a cannabis export reform. In response, Tel Aviv’s cannabis stocks tumbled
Previous Articles
More Articles
